NSE filing, NSE: DHANUKA. Summary written from the filing by ALFA Finder's alert engine.
Dhanuka Agritech Ltd: key numbers
- Share price
- ₹887.70
- Market cap
- ₹4,002 Cr
- Revenue (annual)
- ₹2,020 Cr
- Net profit (annual)
- ₹287.2 Cr
- Promoter holding
- 69.81%+0.00% QoQ
- FII holding
- 1.59%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhanuka Agritech Ltd
All →Dhanuka Agritech Board Meeting Date
Dhanuka Agritech Ltd notified exchanges of a board meeting on 30 October 2026 to consider Q2 and half-year unaudited financial results. The notice is a future meeting intimation with no decision yet taken.
Dhanuka Agritech Management Change
Dhanuka Agritech Limited announced the resignation of Umesh Verma, General Manager-Procurement, effective October 15, 2026. The departure is to pursue other career opportunities.
Dhanuka Agritech Product Launch
Dhanuka Agritech has launched a new herbicide product, Tembotrax, for the domestic Indian market. This herbicide controls broadleaf and grassy weeds in Maize and Sugarcane crops.
Dhanuka Agritech Promoter Buying (Off-Market)
Promoter group members gifted shares to other family members within the promoter group, resulting in an inter-se transfer of equity stakes.
Dhanuka Agritech Other Announcement
Dhanuka Agritech filed its quarterly Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent, confirming dematerialization processing status for the quarter ended September 2026.
Dhanuka Agritech Legal & Regulatory
Dhanuka Agritech received seven demand orders from the Excise & Taxation Department regarding entry tax for FY 2008-09 to 2014-15. The company contests these demands.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date